Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results for the quarter and year ended March 31, 2026.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Laboratories Limited has published its standalone and consolidated audited financial results for Q4 and FY ended March 31, 2026, in compliance with SEBI LODR Regulations. Total income for the year stood at approximately ₹5,548 crore, with net profit of ₹215 crore. Basic EPS for FY26 was ₹1.02 compared to a loss in the prior year. The company swung from a loss position in the previous year (net loss of ₹326.79 crore) to profitability this year. Consolidated balance sheet shows total assets of ₹26,545 crore with reserves of ₹19,093 crore. Results were published in Financial Express (English) and Mumbai Lakshadeep (Marathi) on May 16, 2026.
The company has returned to profitability after reporting losses in the previous fiscal year, a positive development for shareholders. The strong revenue growth and turnaround in earnings per share indicate operational improvement.